The calculation of methotrexate dosage at 50 mg/m is a common practice in oncology and rheumatology. This method utilizes a patient’s body surface area (BSA), expressed in square meters (m), to determine the appropriate quantity of the medication for administration. For instance, if a patient’s BSA is 1.5 m, the prescribed methotrexate dose would be 75 mg (50 mg/m x 1.5 m).
This BSA-based dosage calculation is important because it accounts for individual variations in body size and composition, leading to a more precise and personalized approach to medication delivery. This can contribute to optimized therapeutic outcomes and reduced risk of adverse effects. Historically, fixed-dose regimens were common, but BSA-based dosing has emerged as a more sophisticated strategy to improve patient safety and efficacy.
